Dusa Pharmaceuticals (DUSA) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.12 -0.07%
Financial Fact:
NET INCOME (LOSS): -1.42M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
NET INCOME (LOSS): -1.42M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Dusa Pharmaceuticals (NASDAQ: DUSA) reported Q2 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $9.76 million versus the consensus estimate of $10.3 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
